DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in INCY — Incyte Corp
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,302,454
+$7,246,682 QoQ
Shares Held
183,834
+80.6% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 5.1187484360890805.ToString("F0")%
Shared 0.ToString("F0")%
None 94.88125156391092.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $379,217,691 across 26 Biotechnology names. INCY ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
364,513 | $162,769,634 | |
| 2 | BNTX |
BioNTech SE
|
387,214 | $34,415,577 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,270 | $29,568,932 | |
| 4 | INVA |
Innoviva, Inc.
|
892,336 | $20,791,428 | |
| 5 | INCY |
Incyte Corp
This page
|
183,834 | $17,302,454 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
567,115 | $15,884,891 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
213,363 | $14,536,421 | |
| 8 | EXEL |
Exelixis, Inc.
|
334,487 | $14,346,147 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,302,454 | 183,834 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,055,772 | 101,810 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,555,462 | 100,878 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,895,717 | 218,733 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,837,558 | 162,470 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,173,421 | 45,945 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,387,877 | 81,511 | Shares | Defined | 2026-05-04 | |
| 2024-06-30 | $14,947,982 | 246,585 | Shares | Defined | 2026-05-04 | |
| 2024-03-31 | $9,086,599 | 159,498 | Shares | Defined | 2026-05-04 | |
| 2023-12-31 | $8,005,222 | 127,492 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $14,702,579 | 254,502 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $30,813,375 | 494,994 | Shares | Defined | 2026-05-04 | |
| 2023-03-31 | $33,700,727 | 466,317 | Shares | Defined | 2024-05-17 | |
| 2022-12-31 | $36,126,972 | 449,788 | Shares | Defined | 2024-05-17 | |
| 2022-09-30 | $23,544,844 | 353,314 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,247,096 | 358,656 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $31,782,772 | 400,186 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,373,989 | 141,335 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,416,447 | 35,133 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,955,739 | 35,133 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $43,560 | 536 | Shares | Defined | 2026-05-04 | |
| 2020-12-31 | $373,492 | 4,294 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $812,416 | 9,053 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,307,734 | 12,578 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,049,106 | 55,293 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||